15 matches for your search in the start-up spotlight
rss
BioCopy is a multinational company and focuses on TCR(m)- based immuno-oncology drug development. The BioCopy group is headquartered in Switzerland. The German branch, including a state-of-the-art research and development facility, is situated in Emmendingen, north of Freiburg i. Br. We are ...
SOLID Therapeutics is an early-stage oncology company which is based on research at University of Copenhagen joining expertise in metabolite GPCR structure-based drug discovery in the Schwartz-Frimurer labs at the Novo Nordisk Foundation (NNF) Center for Basic Metabolic Research (CBMR) with the ...
TransCode is an RNA oncology company created on the belief that cancer can be effectively treated using RNA therapeutics. The Company has created a platform of drug candidates designed to target a variety of tumor types with the objective of significantly improving patient outcomes. The Company’s ...
With their Albuplatin project, P4 Therapeutics aims to introduce the next generation of platinum/based anticancer drugs into the clinic.
TOLREMO therapeutics AG ("TOLREMO") is a Swiss biotechnology company that was spun out of ETH Zurich in 2017. Based on cutting-edge science and guided by pioneering real-world medicine, TOLREMO created a broad cancer drug resistance platform that provides a unique entry point into a major ...
